RxDoctor Payments Data

Anthony Christoff, DO

Family Medicine · Colorado Spgs, CONPI 1568591253

Payments from drug & device makers

$1,857in general payments, 2019–2025

Across 96 payments — averaging $19.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$389
  • Takeda Pharmaceuticals U.S.A., Inc.$203
  • Amgen$179
  • Grifols USA, LLC$134
  • AstraZeneca$133
  • E.r. Squibb & Sons, L.L.C.$110
  • plus $710 from 18 others

What the payments were for

  • Food & beverage$1,84599%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,857 in reported general payments places this provider in the 85th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$53,131
Medicare patients
194
Services billed
594

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban40$54,381
XareltoRivaroxaban17$24,986
OzempicSemaglutide16$17,041
JanuviaSitagliptin Phosphate16$12,055
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$8,071
Fentanyl19$5,494
Buprenorphine12$5,176
Levothyroxine Sodium309$3,424
ButransBuprenorphine11$3,384
Gabapentin109$2,532
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen81$2,482
Atorvastatin Calcium244$2,224
SynthroidLevothyroxine Sodium33$2,196
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst22$1,905
Propranolol Hcl ErPropranolol Hcl28$1,596

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$34$54,38140 claims
MerckJanuvia$71$12,05516 claims
AbbVieSynthroid$389$2,19633 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Colorado Spgs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →